Literature DB >> 480153

Physical characterization of solid iopanoic acid forms.

W C Stagner, J K Guillory.   

Abstract

Three solid forms of iopanoic acid were characterized by X-ray diffraction, differential scanning calorimetry, scanning electron microscopy, thermal microscopy, IR spectroscopy, and dissolution studies. X-ray analysis demonstrated that two solid forms were crystalline and that the third was amorphous. The amorphous form had been reported previously as crystalline. Enthalpies and entropies of transition were calculated using differential scanning calorimetry. A fourth form, a benzene solvate, also was isolated but proved to be too unstable at room temperature to permit conclusive characterization. The amorphous form demonstrated a 10-fold greater intrinsic dissolution rate than the commercially available form (Form I). Form II's intrinsic dissolution rate was 1.5 times greater than that of Form I. In powder dissolution studies, the peak solubilities of the different forms followed the same rank order as their intrinsic dissolution rates. Form II was relatively stable in aqueous saturated solutions, but the amorphous form was rapidly converted to Form I under similar conditions.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 480153     DOI: 10.1002/jps.2600680823

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  3 in total

1.  What is the true solubility advantage for amorphous pharmaceuticals?

Authors:  B C Hancock; M Parks
Journal:  Pharm Res       Date:  2000-04       Impact factor: 4.200

2.  Neotame anhydrate polymorphs I: preparation and characterization.

Authors:  Zedong Doug; Brian E Padden; Jonathon S Salsbury; Eric J Munson; Steve A Schroeder; Indra Prakash; David J W Grant
Journal:  Pharm Res       Date:  2002-03       Impact factor: 4.200

3.  Physicochemical characterization of high- and low-melting phenylephrine oxazolidines.

Authors:  Y Qiu; R D Schoenwald; J K Guillory
Journal:  Pharm Res       Date:  1993-10       Impact factor: 4.200

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.